Best Small intestine cancer doctors in Israel: TOP 17 doctors

Prof. Merimsky leads the Unit for Soft Tissue and Bone Oncology at Sourasky Medical Center, specializing in rare tumors like small intestine cancer.

• Over 41 years of experience of oncology experience, focusing on sarcomas and rare cancers
• Senior investigator at Weizmann Institute and Tel-Aviv University
• Member of ESMO Sarcoma Faculty and IASLC ethical committee
• Trained at Institut Gustave Roussy, Paris – Europe's leading sarcoma center

Dr. Pelles Sharon specializes in advanced cancer treatments, including small intestine cancer, at Sourasky Medical Center (Ichilov).

• Offers a range of surgical and non-surgical treatments like SIRT therapy and HIPEC
• Active in clinical research, contributing to studies on oncologic patient attitudes
• Provides immunotherapy and targeted therapy options
• Skilled in liver and pancreatic cancer surgeries

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Wolf leads the Medical Oncology Division at Sourasky Medical Center, one of Israel's largest and most prominent hospitals.

• Head of the Division that treats complex gastrointestinal cancers
• Holds degrees and extensive training in medical oncology
• Experienced in managing rare cancer cases like those in the small intestine
• Works within a major academic medical center for advanced treatment protocols

Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky leads a specialized oncology unit with a focus on small intestine cancer.

• Over 26 years of experience of experience in oncology and internal medicine
• Primary and secondary researcher in phase 1-3 clinical trials
• Trained at Tel Aviv Medical Center, one of Israel's leading hospitals
• Specializes in both diagnosis and treatment of small intestine cancer

Dr. Greenberg is a top specialist in Whipple surgery – a key operation for small intestine cancer – and heads the Colorectal Surgery Department at Sourasky Medical Center.

• Over 35 years of experience of experience as an abdominal surgeon
• Performs both open and minimally invasive surgical techniques
• Leads a dedicated department at a major tertiary hospital

Dr. Klauzner is recognized as one of Israel's best Whipple surgeons – a complex procedure for tumors in the digestive system. He leads the surgery department at Sourasky Medical Center (Ichilov).

• Specializes in gastrointestinal, pancreatic, and colorectal cancer surgeries
• Over 42 years of experience of surgical experience
• Holds the senior position of Chairman of Surgery

36 years of experience specializing in oncology and radiotherapy – Dr. Auala Hubert heads the Gastrointestinal Cancer Center at Hadassah Medical Center.

• Board-certified in oncology and radiotherapy
• Graduated from Hadassah University Hospital
• Fluent in English and Hebrew
• Member of multiple oncology associations

Deputy Head of the Department of Oncology at Rambam Medical Center – a leading role in cancer care.

• Specializes in small intestine cancer treatment
• Works at a top-tier medical center in Israel
• Holds a leadership position in oncology

Dr. Alexander Beny is Director of Gastrointestinal Malignant Service at Rambam Medical Center, specializing in small intestine cancer.

• Board-certified oncologist with European Community Board Examination in Medicine
• Heads the Gastro-intestinal Oncology clinic at Rambam Medical Center
• Trained in modern Brachytherapy Techniques through ESTRO course
• Experienced in both medical and radiation oncology approaches

Dr. Gutman is an oncosurgeon specializing in small intestine cancer at Assuta Medical Center.

• Focuses on surgical oncology with expertise in small intestine cases
• Works at Assuta Medical Center – a leading oncology hospital
• Provides personalized treatment plans for each patient

Specialist in endoscopic surgery – Dr. Kashtan focuses on minimally invasive techniques for small intestine cancer at Assuta Medical Center.

• Trained in advanced endoscopic procedures
• Works at one of Israel's leading oncology centers
• Expertise in small intestine cancer treatment

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.